BE with intravenous solutions? [Design Issues]

posted by raghavendra_s – 2011-05-31 15:23 (5505 d 14:12 ago) – Posting: # 7033
Views: 4,809

❝ Could you please explain why do you think that a bioequivalence study is needed? Please note there is no disintegration, dissolution and absorption.


Dear Dr Dan,

Can't we propose a bioequivalence to regulatory authorities for newer FDC even if the route of administration is IV to investigate or prove that when clubbed each individual component would not have any impact on each other's fate in the body?

Correct me if Iam wrong. How to prove the fractional maximal effect (FME) of synergestic fdc combination.

Thanks and kind regards,

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
384 visitors (0 registered, 384 guests [including 17 identified bots]).
Forum time: 05:35 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5